Background & Sources: Tysabri Progressive Multifocal Leukoencephalopathy lawsuit eligibility overview

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

In-depth resource

Tysabri Progressive Multifocal Leukoencephalopathy lawsuit eligibility overview — Background & Analysis

A focused review of background, context, and source material on this subject.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.